PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET

During the last decade, the discovery of critical tumor targets has boosted the design of targeted therapeutic agents with monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs) receiving most of the attention. Immuno-positron emission tomography (immuno-PET) and TKI-PET, the in vivo tra...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dongen, Guus A. M. S., Poot, Alex J., Vugts, Danielle J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342498/
https://www.ncbi.nlm.nih.gov/pubmed/22270450
http://dx.doi.org/10.1007/s13277-012-0316-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342498/
https://www.ncbi.nlm.nih.gov/pubmed/22270450
http://dx.doi.org/10.1007/s13277-012-0316-4

Ejemplares similares